A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer.
Karen Kelly(Cancer Research Center), Paul A. Bunn(University of Colorado Denver), Zhaoxing Pan(University of Colorado Denver), Sheila A. Prindiville(Memorial Sloan Kettering Cancer Center), Nadine Mikhaeel-Kamel(University of Colorado Denver), James R. Murphy(University of Liverpool)
PubMed
September 1, 2000
Cited by 25
Related Papers
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
|Clinical Cancer Research|2009|1.4k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
|Journal of Allergy and Clinical Immunology|2007|933